首页> 外文期刊>Expert review of anti-infective therapy >Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
【24h】

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.

机译:氟苯达唑:用于淋巴丝虫病和盘尾丝虫病野外计划的候选大型杀虫剂。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A safe, field-usable chemotherapeutic agent that will rapidly kill adult filarial worms is urgently needed in tropical medicine. Ivermectin, distributed as Mectizan? by Merck &: Co. Inc., has had an enormous impact on two major human filarial infections of developing countries, onchocerciasis and lymphatic filariasis [l]. However, this agent works primarily against the microfilarial stage and lacks the ability to rapidly kill the adult parasites. Since the adult worms can survive for many years producing offspring, it has been necessary for control programs to continue drug distribution for more than a decade, for instance, until the adult worms eventually die; a labor-intensive and expensive proposition. Other agents used in filarial control programs, such as diethylcarbamazine and albendazole, may be more effective macrofilaricides than ivermectin, but for various reasons are not suitable, or are unable, to fill the role of a being rapidly acting mac-rofilaricide.
机译:在热带医学中,迫切需要一种安全,可现场使用的化学治疗剂,它将迅速杀死成年的丝虫。伊维菌素,以Mectizan的形式分发?默克公司(Merck&:Co. Inc.)的研究对发展中国家的两种主要人类丝虫感染(盘尾丝虫病和淋巴丝虫病)产生了巨大影响[1]。但是,该试剂主要在微丝期起作用,并且缺乏迅速杀死成人寄生虫的能力。由于成年蠕虫可以在产生后代的情况下存活许多年,因此控制程序有必要继续进行药物分配超过十年,例如,直到成年蠕虫最终死亡。劳动密集且昂贵的主张。丝虫控制程序中使用的其他药物,例如二乙基卡巴马嗪和阿苯达唑,可能比伊维菌素更有效的大杀线虫剂,但由于各种原因,它们不适合或无法填补快速起效的杀线虫剂的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号